Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd., a biomedical company, engages in the research and development, production, sale, and technical service of peptides and small molecule drugs in China. The company offers APIs, including peptides, small molecules, and oligonucleotides; and intermediate products, such as fulvestrant, oseltamivir, and other intermediates. It also provides CRDMO/CMO services. The company was founded in 2009 and is headquartered in Hangzhou, China.

Sector

Healthcare

Industry

Biotechnology

CEO

Tong, Ziquan

Employees

2,028

Website

www.sinopep.com

IPO Date

2021-05-20

Headquarters

Building E, Room 1201, 1203, No. 1378 Wenyi West Road, Cangqian Sub-District, Yuhang District, Hangzhou, Zhejiang Province, 311121, China

Socials

NEWSLETTER

View Data Providers

NEWSLETTER

View Data Providers

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

Jiangsu Sinopep-Allsino Biopharmaceutical 688076

Jiangsu Sinopep-Allsino Biopharmaceutical Earnings Call Summary

Jiangsu Sinopep-Allsino Biopharmaceutical Earnings

Transcripts

Events

About Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.

Jiangsu Sinopep-Allsino Biopharmaceutical
688076